Table 7.
Results of quality assessment of 181 studies—case–control studies: 9 studies. The Joanna Briggs Institute Critical Appraisal Checklist is used
Scoring: Yes = 2 / Unclear = 1 / No = 0 / NA = not applicableQ1: Were the groups comparable other than the presence of disease in cases or the absence of disease in controls? Q2: Were cases and controls matched appropriately? Q3: Were the same criteria used for identification of cases and controls? Q4: Was exposure measured in a standard, valid and reliable way? Q5: Was exposure measured in the same way for cases and controls? Q6: Were confounding factors identified? Q7: Were strategies to deal with confounding factors stated? Q8: Were outcomes assessed in a standard, valid and reliable way for cases and controls? Q9: Was the exposure period of interest long enough to be meaningful? Q10: Was appropriate statistical analysis used? | ||||||||||||
Study (serial no.) | Q1 | 1. Q2 | 2. Q3 | 3. Q4 | 4. Q5 | 5. Q6 | 6. Q7 | 7. Q8 | 8. Q9 | 9. Q10 | Total ( /20) | % |
15 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 17 | 85.0 |
20 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 0 | 2 | 13 | 65.0 |
69 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 16 | 80.0 |
93 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 16 | 80.0 |
98 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 16 | 80.0 |
102 | 1 | 1 | 1 | 2 | 2 | 0 | 0 | 2 | 2 | 2 | 13 | 65.0 |
108 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 15 | 75.0 |
114 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 20 | 100.0 |
179 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 20 | 100.0 |
Studies are described using Serial numbers in Table 3